NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
Achieve TMS joins Greenbrook TMS
Greenbrook will have a national footprint of over 125 TMS Centers from coast-to-coast, enabling us to continue to increase awareness of TMS and to provide more individuals suffering with depression and other mental health disorders with access to this potentially life changing therapy. We are excited to collaborate and expand with the Achieve TMS team who shares our passion for TMS therapy and delivering exceptional patient care.
Bill Leonard,
President and CEO, Greenbrook TMS
Let's see if we might be a good fit
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Share this post
We're Better Together
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Contact Us
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
You might also like
September Suicide Prevention Month. Learn the warning signs of suicide, how to help someone at risk, and where to find 24/7 support.
Greenbrook celebrates the grand opening of our National Center of Excellence in Rockville, MD—advancing access to NeuroStar TMS and SPRAVATO treatment for depression.
If your teen is struggling with depression and antidepressants aren't working, NeuroStar TMS may help. Learn about this FDA-cleared, non-drug therapy and its impressive results in adolescents.
Teen depression affects over 5 million U.S. adolescents. Learn how NeuroStar TMS, FDA-cleared for 15-21, offers a non-drug path to relief.
